Bicycle Therapeutics (BCYC) Capital Expenditures (2018 - 2026)
Bicycle Therapeutics (BCYC) reported Capital Expenditures of $265,000 for Q2 2026, down 46.8% from $498,000 a year earlier and down 62.8% from the prior quarter.
Bicycle Therapeutics (BCYC) Capital Expenditures (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Bicycle Therapeutics' Capital Expenditures came in at $2.23 million, up 16.9% year-over-year; for FY2025, it came in at $2.35 million, up 90.3% from FY2024.
- Capital Expenditures has a five-year compound annual growth rate of 14.4% (FY2020 to FY2025).
- By year, Capital Expenditures came in at $1.24 million in FY2024 (-57.8%), $2.93 million in FY2023 (-84.6%), $18.99 million in FY2022 (+835.3%) and $2.03 million in FY2021 (+69.2%).
- The Q2 2026 figure ranks as the lowest quarterly Capital Expenditures since Q1 2024.
- Year over year, Capital Expenditures gained in five of the last seven quarters, with growth averaging 101.3%.
- The high point for year-over-year Capital Expenditures in five years was Q1 2022 (growth of 663.4%); the low point was Q1 2024 (a decline of 99.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $713,000 (Q1 2026), $574,000 (Q4 2025) and $674,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.18 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 301.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.04 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -3.30 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 587.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 237.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 573.00 Mn |
| 10 | Bicycle Therapeutics | 258.27 Mn | -1.91 Bn | - | 305,000.00 |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 305,000.00 |
| Jun 30, 2026 | 265,000.00 |
| Mar 31, 2026 | 713,000.00 |
| Dec 31, 2025 | 574,000.00 |
| Sep 30, 2025 | 674,000.00 |
| Jun 30, 2025 | 498,000.00 |
| Mar 31, 2025 | 604,000.00 |
| Dec 31, 2024 | 368,000.00 |
| Sep 30, 2024 | 435,000.00 |
| Jun 30, 2024 | 420,000.00 |
| Mar 31, 2024 | 12,000.00 |
| Dec 31, 2023 | 51,000.00 |
| Sep 30, 2023 | 502,000.00 |
| Jun 30, 2023 | 277,000.00 |
| Mar 31, 2023 | 2.10 Mn |
| Dec 31, 2022 | 1.45 Mn |
| Sep 30, 2022 | 2.98 Mn |
| Jun 30, 2022 | 9.80 Mn |
| Mar 31, 2022 | 4.76 Mn |
| Dec 31, 2021 | 1.07 Mn |
Bicycle Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=BCYC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "BCYC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=BCYC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();